Skip to content

Azenta AZTA Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$5.2M+528%

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-16.3%
Enterprise value$1.03B
P/S1.8×-0.2×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's increase (decrease) in contract liabilities and current deferred income?
Azenta (AZTA) reported increase (decrease) in contract liabilities and current deferred income of $3.95M in Q1 2026.
How has Azenta's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Azenta's increase (decrease) in contract liabilities and current deferred income increased by 149.7% year-over-year, from $1.58M to $3.95M.
What is the long-term trend for Azenta's increase (decrease) in contract liabilities and current deferred income?
Over 3 years (2021 to 2024), Azenta's increase (decrease) in contract liabilities and current deferred income has grown at a -3.3% compound annual growth rate (CAGR), from -$3.94M to -$3.56M.